Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer

T
Temel Tirkes, MD

Primary Investigator

Overview

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer.

Description

Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Prostate Carcinoma, Prostate Cancer
  • Age: Between 18 Years - 100 Years
  • Gender: Male

Inclusion Criteria
Recently diagnosed with prostate cancer for whom definitive surgical treatment is indicated
Exclusion Criteria
Not suitable to undergo MRI or receive gadolinium-based contrast agent (severe, untreatable claustrophobia; MRI-incompatible metallic objects or implanted medical devices; renal failure; weight greater than allowable by scanner per institutional standard practice)
Prior surgical and/or non-surgical treatment for prostate cancer
Prior hip replacement or other major pelvic surgery

Updated on 18 Dec 2023. Study ID: 1902624997 (RADY-ECOG-ACRIN-EA8171)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center